Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;47(2):242-252.
doi: 10.23736/S2724-6507.22.03752-6. Epub 2022 Feb 1.

Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders

Nazarii Kobyliak  1   2 , Tetyana Falalyeyeva  3   4 , Yevheniia Kyriachenko  4 , Yuliya Tseyslyer  4 , Oleksandr Kovalchuk  4   5 , Olena Hadiliia  4 , Majid Eslami  6 , Bahman Yousefi  7 , Ludovico Abenavoli  8 , Sharmila Fagoonee  9 , Rinaldo Pellicano  10
Affiliations
Review

Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders

Nazarii Kobyliak et al. Minerva Endocrinol (Torino). 2022 Jun.

Abstract

Akkermansia muciniphila (A. muciniphila) is a mucin-degrading bacterium that commonly lives in the intestinal mucus layer. It is normally detected in human faecal specimens and is one of the few bacteria potentially associated to obesity development. In this narrative review, possible mechanisms that support how A. muciniphila is implicated in the pathogenesis of obesity and metabolic-associated disease are described with the evaluation of its role as an intermediary or independent agent whose manipulation could be useful in the management of metabolic disorders. The ampleness of A. muciniphila is notably diminished in obesity, type 2 diabetes (T2D), non-alcoholic fatty liver disease (NAFLD), cardiometabolic diseases and low-grade inflammation. Furthermore, an inverse relationship between A. muciniphila, body weight and insulin sensitivity has been observed in both humans and animals. Antidiabetic drugs, gastric bypass surgery, prebiotics and biologically active compounds, such as polyphenols or saponins, have been shown to be associated with A. muciniphila relative abundance and thus could have favourable effects on metabolic disorders. Furthermore, A. muciniphila supplementation alone has been correlated with weight reduction and improvement of metabolic disorders, including fat mass gain, adipose tissue inflammation, metabolic endotoxaemia, and insulin resistance. Nevertheless, since the primary beneficial impacts of this bacterium have been predominantly investigated in various preclinical models, these results need to be confirmed in randomized clinical trials.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Supplementary concepts

LinkOut - more resources